vimarsana.com
Home
Live Updates
Outcomes From Two New Head-to-Head Randomized Controlled Tri
Outcomes From Two New Head-to-Head Randomized Controlled Tri
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 -- Teleflex Incorporated , a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association...
Related Keywords
San Antonio ,
Texas ,
United States ,
American ,
Claus Roehrborn ,
Jacqueline Welch ,
Lawrence Keusch ,
European Association Of Urology ,
American Urological Association ,
Ut Southwestern Medical Center ,
Strategy Development ,
Partner National Media Relations Specialist ,
Exchange Commission ,
Teleflex Incorporated ,
American Urological Association Annual Meeting ,
Urological Association Annual Meeting ,
Prostatic Urethral Lift ,
Vice President ,
Global Clinical ,
Scientific Operations ,
User Facility Device Experience ,
Medical Center ,
Advanced Tissue Control ,
Urological Association ,
Minimally Invasive Surgery ,
Initial Treatment ,
Early Patient Experience Following Treatment With ,
Two Contemporary ,
Preliminary Results From ,
Prostate Cancer Prostatic Dis ,
Procedural Context ,
Device Safety ,
Intj Clin Pract ,
Canj Urol ,
Prostate Cancer ,
Prostatic Dis ,
Teleflex Interventional ,
Annual Report ,
Investor Relations ,
Markets ,